We are live on ! Find out more
LABP

Landos Biopharma, Inc. Common Stock
LABP

Delisted

LABP was delisted on the 23rd of May, 2024.

Back to rankings

47 hedge funds and large institutions have $219M invested in Landos Biopharma, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+47
Holders Change %
–
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
47
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$194M
2
RI
RTW Investments
New York
+$55.8M
3
LGM
Logos Global Management
California
+$9.58M
4
O
OrbiMed
New York
+$8.89M
5
DM
Deerfield Management
New York
+$5.87M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Squarepoint
26
Squarepoint
New York
$148K +$200K +1,536 New
Charles Schwab
27
Charles Schwab
California
$130K +$175K +1,344 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$98K +$133K +1,018 New
N
29
Nuveen
North Carolina
$98K +$133K +1,022 New
LCM
30
Laurion Capital Management
New York
$96K +$130K +1,000 New
Teacher Retirement System of Texas
31
Teacher Retirement System of Texas
Texas
$96K +$130K +1,000 New
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$92K +$124K +952 New
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$70K +$95.2K +730 New
Deutsche Bank
34
Deutsche Bank
Germany
$38K +$51.9K +398 New
Wells Fargo
35
Wells Fargo
California
$19K +$25.7K +197 New
UBS Group
36
UBS Group
Switzerland
$18K +$23.9K +183 New
SPIA
37
Steward Partners Investment Advisory
New York
$14.4K +$19.6K +150 New
SO
38
STRS Ohio
Ohio
$14K +$19.6K +150 New
TRCT
39
Tower Research Capital (TRC)
New York
$10K +$13.2K +101 New
Legal & General Group
40
Legal & General Group
United Kingdom
$6K +$7.7K +59 New
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$6K +$7.96K +61 New
Morgan Stanley
42
Morgan Stanley
New York
$5K +$6.26K +48 New
AIP
43
Ameritas Investment Partners
Nebraska
$5K +$6.79K +52 New
Citigroup
44
Citigroup
New York
$4K +$5.48K +42 New
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$2K +$3K +23 New
GWM
46
Geneos Wealth Management
Colorado
$1K +$1.3K +10 New
AIG
47
American International Group
New York
$35 +$48K +368 New
1
2

LABP Hedge Fund Activity: Q1 2021 in Review

47 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Landos Biopharma, Inc. Common Stock (LABP) for Q1 2021, worth a combined $219M.

Buyers outnumbered sellers: 47 funds opened new LABP positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Perceptive Advisors, opening a new position worth an estimated $194M.

  • 47 institutional investors held Landos Biopharma, Inc. Common Stock (LABP) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $219M of Landos Biopharma, Inc. Common Stock stock for Q1 2021.
  • 47 funds opened new Landos Biopharma, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +47 holders.
  • The largest Landos Biopharma, Inc. Common Stock buyer in Q1 2021 was Perceptive Advisors, an estimated $194M added.

Based on aggregated 13F filings for Q1 2021.